Report Detail
Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth (Status and Outlook) 2023-2029
- RnM4501032 |
- 10 January, 2023 |
- Global |
- 100 Pages |
- LPI(LP Information) |
- Other
Developing, optimising, and manufacturing Advanced Therapy Medicinal Products (ATMP’s), such as Cell and Gene Therapy (CGT) products is extremely complex. The choice of a reliable Contract Development Manufacturing Organisation (CDMO) is one of the most critical steps determining your product’s future.
LPI (LP Information)' newest research report, the “Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Industry Forecast” looks at past sales and reviews total world Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services sales for 2023 through 2029. With Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services industry.
This Insight Report provides a comprehensive analysis of the global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services.
The global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services players cover AGC Biologics, BlueReg, Bio Elpida, Celonic, CGT Catapult, Catalent, Cellipont Bioservices, Lonza and Minaris Regenerative Medicine, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene Therapy
Cell Therapy
Tissue Engineered
Others
Segmentation by application
Oncology
Cardiology
Central Nervous System
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AGC Biologics
BlueReg
Bio Elpida
Celonic
CGT Catapult
Catalent
Cellipont Bioservices
Lonza
Minaris Regenerative Medicine
Patheon
Rentschler Biopharma SE
Recipeharm
WuXi Advanced Therapies
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size 2018-2029
- 2.1.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Segment by Type
- 2.2.1 Gene Therapy
- 2.2.2 Cell Therapy
- 2.2.3 Tissue Engineered
- 2.2.4 Others
- 2.3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type
- 2.3.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share by Type (2018-2023)
- 2.4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Segment by Application
- 2.4.1 Oncology
- 2.4.2 Cardiology
- 2.4.3 Central Nervous System
- 2.4.4 Others
- 2.5 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application
- 2.5.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share by Application (2018-2023)
3 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Player
- 3.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Market Share by Players
- 3.1.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue by Players (2018-2023)
- 3.1.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue Market Share by Players (2018-2023)
- 3.2 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services by Regions
- 4.1 Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Regions (2018-2023)
- 4.2 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth (2018-2023)
- 4.3 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth (2018-2023)
- 4.4 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Country (2018-2023)
- 5.2 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type (2018-2023)
- 5.3 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Region (2018-2023)
- 6.2 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type (2018-2023)
- 6.3 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services by Country (2018-2023)
- 7.2 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type (2018-2023)
- 7.3 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services by Region (2018-2023)
- 8.2 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Regions (2024-2029)
- 10.1.1 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Regions (2024-2029)
- 10.1.2 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast
- 10.1.3 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast
- 10.1.4 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast
- 10.1.5 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast
- 10.2 Americas Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Country (2024-2029)
- 10.2.1 United States Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.2.2 Canada Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.2.3 Mexico Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.2.4 Brazil Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3 APAC Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Region (2024-2029)
- 10.3.1 China Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3.2 Japan Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3.3 Korea Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3.4 Southeast Asia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3.5 India Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.3.6 Australia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.4 Europe Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Country (2024-2029)
- 10.4.1 Germany Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.4.2 France Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.4.3 UK Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.4.4 Italy Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.4.5 Russia Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.5 Middle East & Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Region (2024-2029)
- 10.5.1 Egypt Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.5.2 South Africa Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.5.3 Israel Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.5.4 Turkey Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.5.5 GCC Countries Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Forecast
- 10.6 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Type (2024-2029)
- 10.7 Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 AGC Biologics
- 11.1.1 AGC Biologics Company Information
- 11.1.2 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.1.3 AGC Biologics Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 AGC Biologics Main Business Overview
- 11.1.5 AGC Biologics Latest Developments
- 11.2 BlueReg
- 11.2.1 BlueReg Company Information
- 11.2.2 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.2.3 BlueReg Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 BlueReg Main Business Overview
- 11.2.5 BlueReg Latest Developments
- 11.3 Bio Elpida
- 11.3.1 Bio Elpida Company Information
- 11.3.2 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.3.3 Bio Elpida Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Bio Elpida Main Business Overview
- 11.3.5 Bio Elpida Latest Developments
- 11.4 Celonic
- 11.4.1 Celonic Company Information
- 11.4.2 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.4.3 Celonic Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Celonic Main Business Overview
- 11.4.5 Celonic Latest Developments
- 11.5 CGT Catapult
- 11.5.1 CGT Catapult Company Information
- 11.5.2 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.5.3 CGT Catapult Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 CGT Catapult Main Business Overview
- 11.5.5 CGT Catapult Latest Developments
- 11.6 Catalent
- 11.6.1 Catalent Company Information
- 11.6.2 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.6.3 Catalent Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Catalent Main Business Overview
- 11.6.5 Catalent Latest Developments
- 11.7 Cellipont Bioservices
- 11.7.1 Cellipont Bioservices Company Information
- 11.7.2 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.7.3 Cellipont Bioservices Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Cellipont Bioservices Main Business Overview
- 11.7.5 Cellipont Bioservices Latest Developments
- 11.8 Lonza
- 11.8.1 Lonza Company Information
- 11.8.2 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.8.3 Lonza Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 Lonza Main Business Overview
- 11.8.5 Lonza Latest Developments
- 11.9 Minaris Regenerative Medicine
- 11.9.1 Minaris Regenerative Medicine Company Information
- 11.9.2 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.9.3 Minaris Regenerative Medicine Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Minaris Regenerative Medicine Main Business Overview
- 11.9.5 Minaris Regenerative Medicine Latest Developments
- 11.10 Patheon
- 11.10.1 Patheon Company Information
- 11.10.2 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.10.3 Patheon Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Patheon Main Business Overview
- 11.10.5 Patheon Latest Developments
- 11.11 Rentschler Biopharma SE
- 11.11.1 Rentschler Biopharma SE Company Information
- 11.11.2 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.11.3 Rentschler Biopharma SE Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Rentschler Biopharma SE Main Business Overview
- 11.11.5 Rentschler Biopharma SE Latest Developments
- 11.12 Recipeharm
- 11.12.1 Recipeharm Company Information
- 11.12.2 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.12.3 Recipeharm Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Recipeharm Main Business Overview
- 11.12.5 Recipeharm Latest Developments
- 11.13 WuXi Advanced Therapies
- 11.13.1 WuXi Advanced Therapies Company Information
- 11.13.2 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Product Offered
- 11.13.3 WuXi Advanced Therapies Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 WuXi Advanced Therapies Main Business Overview
- 11.13.5 WuXi Advanced Therapies Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services. Industry analysis & Market Report on Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services is a syndicated market report, published as Global Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services Market Growth (Status and Outlook) 2023-2029. It is complete Research Study and Industry Analysis of Advanced Therapy Medicinal Products Contract Development and Manufacturing Organization (CDMO) Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
